Article | June 3, 2022

How eCOAs Can Benefit Clinical Trials

Source: Medable
GettyImages-1194783103 eCOA ps

Clinical outcome assessments (COAs) are designed to enhance the development of new treatments by facilitating a greater understanding of how a patient functions, feels, and survives. Historically, COAs have been completed with paper and pencil, and typically required participants to travel onsite.

Electronic clinical outcome assessments (eCOAs), however, can be recorded either onsite or remotely on an electronic device, such as a smartphone, tablet, laptop, or desktop computer, which means that data can now be reported at defined time points outside of the clinical environment. This gives researchers a more well-rounded understanding of a treatment’s value and adds new data to better assess health related quality of life impacts that patients often highly value

Read on to learn how the built-in flexibility and freedom of eCOAs can enhance many aspects of a clinical trial.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader